Storm Therapeutics

Storm Therapeutics

Storm Therapeutics

STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNAmodifying enzymes for the treatment of cancer.
Type
B2b
Founded
2015
Raised
$5.4M
Follow us
Alexa global traffic share
Latest funding
£4,000,000
Venture capital (Series A) - 2018
Taiho Ventures LLC
Undisclosed amount
Seed fund - 2015
Team Size
10+
Employees
PE HUB

VC-backed STORM Therapeutics appoints Nobel Prize winner as scientific adviser

Robotics Science Health
£4,000,000 Venture capital (Series A)
FinSMEs

Storm Therapeutics Raises £4M in Series A Funding

Funding Science